تصفح Pharmacy Research حسب المؤلف "Elzouki, Abdel-Naser"
-
Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population
Cyprian, Farhan S.; Suleman, Muhammad; Abdelhafez, Ibrahim; Doudin, Asmma; Masud Danjuma, Ibn Mohammed; Mir, Fayaz Ahmad; Parray, Aijaz; Yousaf, Zohaib; Siddiqui, Mohammed Yaseen Ahmed; Abdelmajid, Alaaedin; Mulhim, Mohammad; Al-Shokri, Shaikha; Abukhattab, Mohammad; Shaheen, Ranad; Elkord, Eyad; Al-khal, Abdul Latif; Elzouki, Abdel Naser; Girardi, Guillermina... more authors ... less authors ( Frontiers Media S.A. , 2021 , Article)Coronavirus disease-2019 (COVID-19) was declared as a pandemic by WHO in March 2020. SARS-CoV-2 causes a wide range of illness from asymptomatic to life-threatening. There is an essential need to identify biomarkers to ... -
Genetic and non-genetic factors impact on inr normalization in preprocedural warfarin management
Eljilany, Islam; Elarref, Mohamed; Shallik, Nabil; Elzouki, Abdel Naser; Bader, Loulia; El-Bardissy, Ahmed; Abdelsamad, Osama; Al-Badriyeh, Daoud; Cavallari, Larisa H.; Elewa, Hazem... more authors ... less authors ( Dove Medical Press , 2021 , Article)Background: Annually, 10% of warfarin patients will likely need to stop warfarin prior to elective surgery to achieve a baseline international normalization ratio (INR) level (INR ≤ 1.2) at the time of the procedure. This ...